Imperva to Present at Piper Jaffray Technology Symposium Series

REDWOOD SHORES, Calif.--(BUSINESS WIRE)-- Imperva, Inc. (NYSE: IMPV), committed to protecting business-critical data and applications in the cloud and on-premises, today announced scheduled participation at the Piper Jaffray Technology Symposium Series in New York, NY –Terry Schmid, CFO to present on Wednesday, March 9, 2016 at 10:30 a.m. Eastern Time (7:30 a.m. Pacific Time).

A live webcast, as well as the replay, of these presentations will be accessible from the investors page of the Imperva’s website at www.imperva.com.

About Imperva

Imperva® (NYSE: IMPV) is a leading provider of cyber security solutions that protect business-critical data and applications. The company’s SecureSphere, Incapsula and Skyfence product lines enable organizations to discover assets and risks, protect information wherever it lives – in the cloud and on-premises – and comply with regulations. The Imperva Application Defense Center, a research team comprised of some of the world’s leading experts in data and application security, continually enhances Imperva products with up-to-the-minute threat intelligence, and publishes reports that provide insight and guidance on the latest threats and how to mitigate them. Imperva is headquartered in Redwood Shores, California. Learn more: www.imperva.com, our blog, on Twitter.

© 2016 Imperva, Inc. All rights reserved. Imperva, the Imperva logo, SecureSphere, Incapsula and Skyfence are trademarks of Imperva, Inc. and its subsidiaries.

View source version on businesswire.com: http://www.businesswire.com/news/home/20160303005334/en/

Investor Relations:
Seth Potter, 646-277-1230
[email protected]
[email protected]

Source: Imperva, Inc.

You May Also Be Interested In

• Skyservice™ Expands Bombardier Authorized Service Facility Network with Vancouver Addition
• Form 8.3 - Ramsdens Holdings Plc
• Saga Metals Consolidates Legacy Lithium Project and Expands Large Contiguous Lithium-Focused Land Package in Eastern James Bay, Quebec Amid Spodumene Price Rally